Mark P. Callery

13.6k total citations · 2 hit papers
190 papers, 9.0k citations indexed

About

Mark P. Callery is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mark P. Callery has authored 190 papers receiving a total of 9.0k indexed citations (citations by other indexed papers that have themselves been cited), including 112 papers in Surgery, 109 papers in Oncology and 69 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mark P. Callery's work include Pancreatic and Hepatic Oncology Research (91 papers), Gallbladder and Bile Duct Disorders (43 papers) and Pancreatitis Pathology and Treatment (40 papers). Mark P. Callery is often cited by papers focused on Pancreatic and Hepatic Oncology Research (91 papers), Gallbladder and Bile Duct Disorders (43 papers) and Pancreatitis Pathology and Treatment (40 papers). Mark P. Callery collaborates with scholars based in United States, Netherlands and Israel. Mark P. Callery's co-authors include Charles M. Vollmer, Wande B. Pratt, Tara S. Kent, Elliot L. Chaikof, M. Wayne Flye, Frank J. Vittimberga, Richard A. Perugini, L. William Traverso, David C. Linehan and Elliot K. Fishman and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Mark P. Callery

185 papers receiving 8.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Prospectively Validated Clinical Risk Score Accurately Predicts Pancreatic Fistula after Pancreatoduodenectomy

2012 874 citations Mark P. Callery, Tara S. Kent et al. profile →
Pretreatment Assessment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement

2009 641 citations Mark P. Callery et al. profile →

Peers

Countries citing papers authored by Mark P. Callery

Since Specialization

Citations

This map shows the geographic impact of Mark P. Callery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark P. Callery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark P. Callery more than expected).

Fields of papers citing papers by Mark P. Callery

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark P. Callery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark P. Callery. The network helps show where Mark P. Callery may publish in the future.

Co-authorship network of co-authors of Mark P. Callery

This figure shows the co-authorship network connecting the top 25 collaborators of Mark P. Callery. A scholar is included among the top collaborators of Mark P. Callery based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark P. Callery. Mark P. Callery is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Patients’ perceptions of the post-pancreatectomy discharge process 2023 ·HPB ·(unknown), (unknown), Ammara A. Watkins, Manuel Castillo‐Angeles, (unknown), Mark P. Callery, Tara S. Kent	0
2	Predictors of non-home discharge after pancreatoduodenectomy in patients aged 80 years and above 2023 ·HPB ·(unknown), (unknown), (unknown), Mark P. Callery, Tara S. Kent	2
3	Biliary palliation for unresectable pancreatic adenocarcinoma: surgical bypass or self-expanding metal stent? 2019 ·HPB ·Kathryn A. Stackhouse, Alessandra Storino, Ammara A. Watkins, William E. Gooding, Mark P. Callery, Tara S. Kent, Mandeep Sawhney, A. James Moser	3
4	Resection of oligometastatic pancreatic ductal adenocarcinoma: a systematic review and meta-analysis 2019 ·HPB ·(unknown), Courtney E. Barrows, Mark P. Callery, (unknown), Tara S. Kent	0
5	Braden scale for pressure ulcer risk predicts rehabilitation placement after pancreatic resection 2018 ·HPB ·Ammara A. Watkins, Manuel Castillo‐Angeles, (unknown), Camila R. Guetter, Mariam F. Eskander, (unknown), (unknown), Jennifer F. Tseng, A. James Moser, Mark P. Callery, Tara S. Kent	15
6	Hemorrhage after pancreaticoduodenectomy: does timing matter? 2016 ·HPB ·Gyulnara G. Kasumova, Mariam F. Eskander, Tara S. Kent, Sing Chau Ng, A. James Moser, Muneeb Ahmed, Douglas K. Pleskow, Mark P. Callery, Jennifer F. Tseng	20
7	Comparing the burden of pancreatic fistulas after pancreatoduodenectomy and distal pancreatectomy 2015 ·Surgery ·(unknown), John D. Christein, Mark P. Callery, Stephen W. Behrman, Jeffrey A. Drebin, Robert H. Hollis, Tara S. Kent, Benjamin C. Miller, Michael H. Sprys, Ammara A. Watkins, Steven M. Strasberg, Charles M. Vollmer	84
8	A nationwide assessment of outcomes after bile duct reconstruction 2015 ·HPB ·Mariam F. Eskander, Lindsay A. Bliss, (unknown), Susanna W.L. de Geus, Sing Chau Ng, Mark P. Callery, Tara S. Kent, A. James Moser, Khalid Khwaja, Jennifer F. Tseng	3
9	Prophylactic octreotide for pancreatoduodenectomy: more harm than good? 2014 ·HPB ·Matthew T. McMillan, John D. Christein, Mark P. Callery, Stephen W. Behrman, Jeffrey A. Drebin, Tara S. Kent, Benjamin C. Miller, Russell S. Lewis, Charles M. Vollmer	57
10	Robotic Surgery for Benign Duodenal Tumors 2014 ·Journal of Gastrointestinal Surgery ·Stephanie Downs‐Canner, (unknown), (unknown), Brian A. Boone, Amer H. Zureikat, Melissa E. Hogg, David L. Bartlett, Mark P. Callery, Tara S. Kent, Herbert J. Zeh, A. James Moser	28
11	Readmission following pancreatectomy: what can be improved? 2013 ·HPB ·Charity C. Glass, Stephen Gondek, Charles M. Vollmer, Mark P. Callery, Tara S. Kent	24
12	A Root-Cause Analysis of Mortality Following Major Pancreatectomy 2011 ·Journal of Gastrointestinal Surgery ·Charles M. Vollmer, Norberto Sánchez, Stephen Gondek, John C. McAuliffe, Tara S. Kent, John D. Christein, Mark P. Callery	182
13	A 21-Year-Old Man With Chronic Pancreatitis 2008 ·JAMA ·Mark P. Callery	1
14	Predominant Bcl-XL Knockdown Disables Antiapoptotic Mechanisms: Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Based Triple Chemotherapy Overcomes Chemoresistance in Pancreatic Cancer Cells In vitro 2005 ·Cancer Research ·Jirong Bai, Jianhua Sui, Aram N. Demirjian, Charles M. Vollmer, Wayne A. Marasco, Mark P. Callery	101
15	Chronic Cough due to Gastroesophageal Reflux Disease 2002 ·CHEST Journal ·Richard S. Irwin, John K. Zawacki, (unknown), Cynthia T. French, Mark P. Callery	67
16	Hemodynamic and Metabolic Variables Predict Porcine ex Vivo Liver Function 2001 ·Journal of Surgical Research ·Rocco Ricciardi, (unknown), Steven H. Quarfordt, Frank J. Vittimberga, Robin D. Kim, Susan E. Donohue, Suzanne M. Wheeler, Saif Anwaruddin, Mark P. Callery, (unknown)	12
17	Sodium Salicylate Inhibits Macrophage TNF-α Production and Alters MAPK Activation 1999 ·Journal of Surgical Research ·Frank J. Vittimberga, Theodore P. McDade, Richard A. Perugini, Mark P. Callery	28
18	Reduced Survival in Patients With Ductal Pancreatic Adenocarcinoma Associated With CDKN2 Mutation 1996 ·JNCI Journal of the National Cancer Institute ·Detlef K. Bartsch, Douglas W. Shevlin, Mark P. Callery, Jeffrey A. Norton, Samuel A. Wells, Paul J. Goodfellow	30
19	Imaging of the common bile duct during laparoscopic cholecystectomy: sonography versus videofluoroscopic cholangiography. 1995 ·American Journal of Roentgenology ·Sharlene A. Teefey, Nathaniel J. Soper, W D Middleton, Dennis M. Balfe, James A. Brink, Steven M. Strasberg, Mark P. Callery	31
20	Kupffer cell tumor necrosis factor-α production is suppressed during liver regeneration 1991 ·Journal of Surgical Research ·Mark P. Callery, (unknown), M. Wayne Flye	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact